Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Aug 9.
doi: 10.1007/s13304-024-01919-y. Online ahead of print.

Advocating for a "shift-to-left" in transplant oncology: left grafts, RAPID and dual graft

Affiliations

Advocating for a "shift-to-left" in transplant oncology: left grafts, RAPID and dual graft

Umberto Cillo et al. Updates Surg. .

Abstract

The extension of liver transplantation to new oncologic indications might exacerbate the shortage of grafts. Living donor liver transplantation (LDLT) may emerge as a viable resource, although its diffusion in the Western world is still very limited. Several groups have advocated for minimizing the impact on donors by reducing the extent of donor hepatectomy, i.e., shifting from right-lobe to left-lobe or left-lateral segment donation ("shift-to-left"). This is particularly relevant when dealing with non-established indications and could make it more acceptable both for potential donors and for the recipients. Left grafts can be transplanted straightforward, despite a higher risk of small-for-size syndrome, or they can be used in the setting of dual-graft LDLT or RAPID procedures, despite technical complexity. This review will expose the most relevant features of each technique, highlighting their strengths and pitfalls and focusing on outcomes. This wide set of tools should be available at high-volume transplant centers, to propose the best technique to adapt to donor-recipient matching.

Keywords: Dual graft; LDLT; Liver transplantation; Living donor; RAPID.

PubMed Disclaimer

References

    1. Sapisochin G, Hibi T, Toso C, Man K, Berenguer M, Heimbach J et al (2021) Transplant oncology in primary and metastatic liver tumors: principles, evidence, and opportunities. Ann Surg 273(3):483–493 - PubMed - DOI
    1. Vitale A, Cabibbo G, Iavarone M, Viganò L, Pinato DJ, Ponziani FR et al (2023) Personalised management of patients with hepatocellular carcinoma: a multiparametric therapeutic hierarchy concept. Lancet Oncol 24(7):e312–e322 - PubMed - DOI
    1. Tan EK, Taner T, Heimbach JK, Gores GJ, Rosen CB (2020) Liver transplantation for peri-hilar cholangiocarcinoma. J Gastrointest Surg Off J Soc Surg Aliment Tract 24(11):2679–2685 - DOI
    1. Ziogas IA, Giannis D, Economopoulos KP, Hayat MH, Montenovo MI, Matsuoka LK et al (2021) Liver transplantation for intrahepatic cholangiocarcinoma: a meta-analysis and meta-regression of survival rates. Transplantation 105(10):2263–2271 - PubMed - DOI
    1. Sapisochin G, Facciuto M, Rubbia-Brandt L, Marti J, Mehta N, Yao FY et al (2016) Liver transplantation for “very early” intrahepatic cholangiocarcinoma: International retrospective study supporting a prospective assessment. Hepatology 64(4):1178–1188 - PubMed - DOI

LinkOut - more resources